Stealth BioTherapeutics Corp. (MITO:NASDAQ) Investor Relations Material

Overview

Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company focused on finding treatments for diseases that involve mitochondrial dysfunction. Mitochondria are crucial for normal organ function, and dysfunctional mitochondria are involved in rare genetic diseases and common age-related diseases. The company believes that their lead candidate, elamipretide, could successfully treat metabolic cardiomyopathies, mitochondrial diseases involving nuclear DNA mutations, and ophthalmic diseases related to mitochondrial dysfunction.

Annual Reports

Frequently Asked Questions

What is Stealth BioTherapeutics Corp.'s ticker?

Stealth BioTherapeutics Corp.'s ticker is MITO

What exchange is Stealth BioTherapeutics Corp. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Stealth BioTherapeutics Corp.'s headquarters?

They are based in Newton, Massachusetts

How many employees does Stealth BioTherapeutics Corp. have?

There are 51-200 employees working at Stealth BioTherapeutics Corp.

What is Stealth BioTherapeutics Corp.'s website?

It is https://www.stealthbt.com/

What type of sector is Stealth BioTherapeutics Corp.?

Stealth BioTherapeutics Corp. is in the Healthcare sector

What type of industry is Stealth BioTherapeutics Corp.?

Stealth BioTherapeutics Corp. is in the Biotechnology industry

Who are Stealth BioTherapeutics Corp.'s peers and competitors?

The following five companies are Stealth BioTherapeutics Corp.'s industry peers:

- Zosano Pharma Corporation

- Plus Therapeutics

- Adial Pharmaceuticals, Inc

- Artelo Biosciences

- Insys Therapeutics Inc